Xiaolong Liu

135PUBLICATIONS
115CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Predictive and prognostic markersApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Molecular targetsImmunogenetics (incl. genetic immunology)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (135)

|Aug 03, 2026
Overcoming Tumor Hypoxia and Adenosine-mediated Immunosuppression for Boosting Photodynamic Therapy and Systemic Antitumor Immune Responses.

|Jul 29, 2026
Integrated Radioproteomic Modeling for Early Recurrence Prediction and Metabolic Characterization in Hepatocellular Carcinoma.

|Apr 24, 2026
T Cell Heterogeneity Shaped by Alternative Splicing Predicts Prognosis in Hepatocellular Carcinoma.

|Apr 17, 2026
Neoantigens and shared MICB α3 antigen dual-targeted vaccine generates potent antitumor immunity.

|Mar 16, 2026
Sequential personalized neoantigen vaccination following first-line treatments demonstrates safety and efficacy in advanced hepatocellular carcinoma.

Zhixiong Cai, Liman Qiu, Ling Li

|Mar 07, 2026
A Dual-Metabolic NIR-II Probe for In Vivo Imaging of Tumor-Infiltrating Lymphocytes.

Yike Cai, Rui Li, Yan Peng

Pageof 23

Frequent Collaborators

21 joint publications

Da Zhang

20 joint publications

Ming Wu

17 joint publications

Yongyi Zeng

16 joint publications

Dianping Tang